InvestorsHub Logo
Followers 44
Posts 4307
Boards Moderated 0
Alias Born 09/01/2017

Re: Hansm7777 post# 277125

Monday, 04/13/2020 7:43:15 PM

Monday, April 13, 2020 7:43:15 PM

Post# of 700697
Re Duffy’s coming and going, one could conjecture that trials and sales of a combination of Merck and NWBO treatments may be positioned better if both treatments are approved in their own right. Merck is there already and DCVax-L obviously isn’t quite there. Could Duffy have been made available to NWBO at a key time to help with the SAP and other approval late steps? Duffy was also privy to an up close and personal look at NWBO that might better inform Merck for M&A or other business reasons.

An optimist may imagine a scenario where Duffy successfully contributed to the cause of helping achieve approval of DCVax.

A pessimist may imagine negative scenarios, as a number of posters have offered.

We shall hopefully soon find out!

Full disclosure - I’m a long time NWBO long.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News